Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kinross Gold
KGC
$32.3B
| $116M | 0.16% |
32,983,372
-5,835,100
| -15% | -$20.9M |
|
127
Annaly Capital Management
NLY
$17.4B
| $115M | 0.16% |
2,596,132
+452,205
| +21% | +$19.2M |
|
|
AZPN
128
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $115M | 0.16% |
1,952,300
+343,800
| +21% | +$20.3M |
|
129
Welltower
WELL
$163B
| $113M | 0.16% |
1,595,500
-241,700
| -13% | -$16.3M |
|
130
CVS Health
CVS
$120B
| $111M | 0.16% |
1,414,005
+689,500
| +95% | +$55M |
|
|
HA
131
DELISTED
Hawaiian Holdings, Inc.
HA
| $111M | 0.15% |
2,381,200
-112,900
| -5% | -$5.78M |
|
132
Capitol Federal Financial
CFFN
$1.09B
| $109M | 0.15% |
7,480,897
+1,024,039
| +16% | +$15.7M |
|
133
Ameren
AEE
$29.8B
| $109M | 0.15% |
2,004,400
+276,800
| +16% | +$14.8M |
|
134
Post Holdings
POST
$3.56B
| $108M | 0.15% |
1,888,150
+276,263
| +17% | +$15.2M |
|
135
Equity Lifestyle Properties
ELS
$12.4B
| $107M | 0.15% |
2,770,400
+230,800
| +9% | +$8.75M |
|
136
ICU Medical
ICUI
$4.55B
| $106M | 0.15% |
696,849
-42,851
| -6% | -$6.26M |
|
137
Synchrony
SYF
$25.5B
| $106M | 0.15% |
+3,099,700
| New | +$111M |
|
138
Progressive
PGR
$123B
| $105M | 0.15% |
2,684,500
-58,369
| -2% | -$2.23M |
|
|
SAFM
139
DELISTED
Sanderson Farms Inc
SAFM
| $105M | 0.15% |
1,011,000
+44,983
| +5% | +$4.24M |
|
140
BlackBerry
BB
$5.26B
| $104M | 0.15% |
13,466,143
-1,203,057
| -8% | -$8.56M |
|
141
Tractor Supply
TSCO
$18.4B
| $103M | 0.14% |
+7,450,140
| New | +$108M |
|
|
COL
142
DELISTED
Rockwell Collins
COL
| $103M | 0.14% |
1,057,600
+60,900
| +6% | +$5.73M |
|
143
Fidelity National Information Services
FIS
$22.1B
| $102M | 0.14% |
1,284,801
+117,400
| +10% | +$9.44M |
|
144
Usana Health Sciences
USNA
$254M
| $101M | 0.14% |
1,761,666
+128,766
| +8% | +$7.69M |
|
145
Bath & Body Works
BBWI
$3.81B
| $101M | 0.14% |
+2,658,972
| New | +$120M |
|
146
Allstate
ALL
$66.3B
| $101M | 0.14% |
1,239,600
+591,300
| +91% | +$46.5M |
|
147
TFS Financial
TFSL
$4.83B
| $100M | 0.14% |
6,044,122
+62,100
| +1% | +$1.09M |
|
148
Dick's Sporting Goods
DKS
$18.4B
| $100M | 0.14% |
2,054,600
+1,662,700
| +424% | +$84.2M |
|
|
LOGM
149
DELISTED
LogMein, Inc.
LOGM
| $99.5M | 0.14% |
1,020,142
+62,342
| +7% | +$6.2M |
|
150
Baxter International
BAX
$14.3B
| $98.4M | 0.14% |
1,897,115
+1,833,015
| +2,860% | +$90.1M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.